BioNTech SE (BNTX) Shares Outstanding (Diluted Average) (2023 - 2024)
BioNTech SE (BNTX) posted Shares Outstanding (Diluted Average) of $1912.8 for Q4 2024, up 115.03% on a QoQ basis from $889.56 in Q3 2024, and down 53.58% year-over-year from $4120.8 in Q1 2024.
BioNTech SE (BNTX) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $1912.8 in Q4 2024.
- In Q4 2024, Shares Outstanding (Diluted Average) fell 53.58% year-over-year to $1912.8; the TTM figure through Dec 2024 stood at $1912.8 (down 53.58% YoY), while the FY2024 annual figure was $1912.8, down 53.58% from the prior year.
- Shares Outstanding (Diluted Average) climbed to $1912.8 in Q4 2024, from $889.56 in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $4120.8 in Q4 2023 and bottomed at $889.56 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,912.79 |
| Sep 30, 2024 | 889.56 |
| Dec 31, 2023 | 4,120.85 |
| Sep 30, 2023 | 2,111.87 |